ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Letter: Weinstein’s Former Fellows Express “Shock” At Allegations

December 1, 1995

Smoking Program May Have Succeeded, Rauscher Says, Looking At Budget Texas Institutions Form Join Dental Oncology Dept.

July 23, 1976

Cooperative Group Chairmen Unhappy Over Contracts They Missed, NCI Protocol Review

January 13, 1978

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds

June 28, 2002